Carmichael Hill & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $136K | Buy |
1,142
+10
| +0.9% | +$1.19K | 0.05% | 205 |
|
|
2024
Q2 | $162K | Hold |
1,132
| – | – | 0.06% | 179 |
|
|
2024
Q1 | $145K | Sell |
1,132
-300
| -21% | -$38.5K | 0.06% | 197 |
|
|
2023
Q4 | $148K | Hold |
1,432
| – | – | 0.06% | 188 |
|
|
2023
Q3 | $130K | Hold |
1,432
| – | – | 0.06% | 189 |
|
|
2023
Q2 | $116K | Sell |
1,432
-200
| -12% | -$16.2K | 0.05% | 198 |
|
|
2023
Q1 | $130K | Hold |
1,632
| – | – | 0.06% | 183 |
|
|
2022
Q4 | $110K | Hold |
1,632
| – | – | 0.06% | 191 |
|
|
2022
Q3 | $81K | Hold |
1,632
| – | – | 0.04% | 213 |
|
|
2022
Q2 | $91K | Hold |
1,632
| – | – | 0.05% | 208 |
|
|
2022
Q1 | $91K | Hold |
1,632
| – | – | 0.04% | 214 |
|
|
2021
Q4 | $91K | Hold |
1,632
| – | – | 0.04% | 209 |
|
|
2021
Q3 | $78K | Hold |
1,632
| – | – | 0.04% | 215 |
|
|
2021
Q2 | $68K | Buy |
1,632
+18
| +1% | +$750 | 0.03% | 237 |
|
|
2021
Q1 | $54K | Hold |
1,614
| – | – | 0.03% | 265 |
|
|
2020
Q4 | $56K | Hold |
1,614
| – | – | 0.03% | 245 |
|
|
2020
Q3 | $56K | Hold |
1,614
| – | – | 0.04% | 230 |
|
|
2020
Q2 | $53K | Hold |
1,614
| – | – | 0.04% | 226 |
|
|
2020
Q1 | $49K | Hold |
1,614
| – | – | 0.04% | 214 |
|
|
2019
Q4 | $47K | Buy |
+1,614
| New | +$47K | 0.03% | 253 |
|